Completed PHASE4 Interventional NCT00479453
Lilly's Emotional and Physical Symptoms of Depression (LEAPS)
Sponsor: Eli Lilly and Company
Conditions
Major Depressive Disorder
Interventions
duloxetine hydrochloride
Updated 1 time since 2017 Last updated: May 25, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00479453, this PHASE4 trial focuses on Major Depressive Disorder and remains completed. Sponsored by Eli Lilly and Company, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Eli Lilly and Company
Data source: Eli Lilly and Company
For direct contact, visit the study record on ClinicalTrials.gov .